Hypoglycaemic activity of biosynthesized copper oxide nanoparticles in alloxan-induced diabetic Wister rats.
Maimuna Bello UmarAugustine Innalegwu DanielJimoh Oladejo TijaniRebecca Olufemi AkinleyeEnriquay SmithMarshall KeysterAshwil KleinPublished in: Endocrinology, diabetes & metabolism (2023)
The green synthesized CuO-NPs nanoparticles significantly reduced (p < 0.05) blood glucose levels in rats and other associated indices and could serve as drug lead in the treatment of diabetes.